1. Factors Associated With Outcomes and Response to Therapy in Patients With Infiltrative Hepatocellular Carcinoma 
Neil Mehta, Nicholas Fidelman, Monika Sarkar, Francis Y. Yao 
Clinical Gastroenterology and Hepatology 
Volume 11, Issue 5, Pages (May 2013)
DOI: /j.cgh
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Typical appearance of iHCC (A). Coronal cross-sectional image demonstrating large, ill-defined iHCC in right hepatic lobe (B). On angiogram, this lesion demonstrates minimal hypervascularity (C). After TACE, the angiogram demonstrates only patchy and diffuse ethiodized oil uptake.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Kaplan–Meier survival curve for iHCC patients treated with (A) TACE vs no therapy and (B) sorafenib vs no therapy.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions